mesalamine has been researched along with Lupus Erythematosus, Systemic in 8 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Coexistence of systemic lupus erythematosus (SLE) should be considered in patients with inflammatory bowel disease (IBD) and complex extraintestinal manifestations and the diagnosis of IBD could be established either before or after the diagnosis of SLE." | 2.48 | Inflammatory bowel disease and lupus: a systematic review of the literature. ( Katsanos, KH; Tsianos, EV; Voulgari, PV, 2012) |
| "Systemic lupus erythematosus is frequently accompanied by gastrointestinal symptoms, but colonic lesions are quite rare, and the regular treatment is not fixed yet." | 1.33 | Two cases of systemic lupus erythematosus complicated with colonic ulcers. ( Chino, Y; Goto, D; Hayashi, T; Ito, S; Matsumoto, I; Miyahara, S; Soeda, A; Sumida, T; Takahashi, R; Tsutsumi, A, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Yamashita, M | 1 |
| Nishimura, K | 1 |
| Shirasugi, I | 1 |
| Ichise, Y | 1 |
| Ueda, Y | 1 |
| Saegusa, J | 1 |
| Bar Yehuda, S | 1 |
| Axlerod, R | 1 |
| Toker, O | 1 |
| Zigman, N | 1 |
| Goren, I | 1 |
| Mourad, V | 1 |
| Lederman, N | 1 |
| Cohen, N | 1 |
| Matz, E | 1 |
| Dushnitzky, D | 1 |
| Gavish, M | 1 |
| Borovsky, N | 1 |
| Schwarts, D | 1 |
| Dotan, I | 1 |
| Turner, D | 1 |
| Hashimoto, Y | 1 |
| Endo, Y | 1 |
| Kuroki, Y | 1 |
| Yoshikumi, H | 1 |
| Yoshiba, M | 1 |
| Katsanos, KH | 1 |
| Voulgari, PV | 1 |
| Tsianos, EV | 1 |
| Miyahara, S | 1 |
| Ito, S | 1 |
| Soeda, A | 1 |
| Chino, Y | 1 |
| Hayashi, T | 1 |
| Takahashi, R | 1 |
| Goto, D | 1 |
| Matsumoto, I | 1 |
| Tsutsumi, A | 1 |
| Sumida, T | 1 |
| Ohnishi, A | 1 |
| Kirkpatrick, AW | 1 |
| Bookman, AA | 1 |
| Habal, F | 1 |
| Gunnarsson, I | 1 |
| Forslid, J | 1 |
| Ringertz, B | 1 |
2 reviews available for mesalamine and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Inflammatory bowel disease and lupus: a systematic review of the literature.
Topics: Adalimumab; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, | 2012 |
[Drug-induced pericarditis].
Topics: Adrenal Cortex Hormones; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineopla | 2007 |
6 other studies available for mesalamine and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Severe Lupus Myocarditis Preceded by Mesalazine-induced Lupus.
Topics: Adult; Antibodies, Antinuclear; Cyclophosphamide; Female; Humans; Immunoglobulins, Intravenous; Lupu | 2023 |
The Association of Inflammatory Bowel Diseases with Autoimmune Disorders: A Report from the epi-IIRN.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Autoimmune Diseases; Biological Products; Case | 2019 |
Collagenous colitis with unique colonoscopic findings.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Colitis, Collagenous; Colonoscopy; Diagnosis, | 2008 |
Two cases of systemic lupus erythematosus complicated with colonic ulcers.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Colitis, Ulcerative; Colonoscopy; Diagnosis, | 2005 |
Lupus-like syndrome caused by 5-aminosalicylic acid in patients with inflammatory bowel disease.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Antinuclear; Connective Tissue Dis | 1999 |
Mesalazine-induced lupus syndrome.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Female; Humans; Lupus Erythematosus, Systemi | 1999 |